Ground Swell Capital’s ANI Pharmaceuticals ANIP Stock Holding History

Ground Swell Capital’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$24K	Buy	+833	New	+$25K	0.05%	448

Other funds holding ANIP

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return

Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Ground Swell Capital's ANIP Position: Q3 2014 in Review

Ground Swell Capital opened a new position in ANI Pharmaceuticals (ANIP) in Q3 2014: 833 shares worth $24K. The stake represents 0.05% of the portfolio and ranks #448 among its holdings.

72 funds tracked by Wall St. Rank hold ANIP as of Q3 2014.

Ground Swell Capital held 833 shares of ANI Pharmaceuticals worth $24K as of Q3 2014.
ANI Pharmaceuticals was a new Ground Swell Capital position in Q3 2014.
ANI Pharmaceuticals made up 0.05% of Ground Swell Capital's portfolio in Q3 2014, its #448 holding.
72 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.